Equities

Zhejiang Gongdong Medical Technology Co Ltd

605369:SHH

Zhejiang Gongdong Medical Technology Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)29.93
  • Today's Change-1.31 / -4.19%
  • Shares traded485.11k
  • 1 Year change-27.08%
  • Beta1.4526
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Zhejiang Gongdong Medical Technology Co Ltd is a China-based company principally engaged in the research and development, production and sales of disposable medical consumables. The Company's main products cover vacuum blood collection systems, laboratory testing consumables, body fluid collection consumables, medical care consumables and pharmaceutical packaging materials. Its products include disposable vacuum blood collection tubes, petri dishes, culture plates, cuvettes, pipette tips, disposable sterile sampling swabs, dispensers, dressing containers and others. The Company's products are applied in clinical diagnosis and nursing, scientific research and testing, pharmaceutical packaging and other fields. The Company distributes its products in the domestic market and to overseas markets, including many countries in North America, Asia, South America, Africa and Europe.

  • Revenue in CNY (TTM)1.10bn
  • Net income in CNY162.27m
  • Incorporated2019
  • Employees1.67k
  • Location
    Zhejiang Gongdong Medical Technology Co LtdNo. 10Beiyuan Avenue, Huangyan DistrictTAIZHOU 318020ChinaCHN
  • Phone+86 57 684081101
  • Fax+86 57 684050789
  • Websitehttps://en.gongdong.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Sino Medical Sciences Technology Inc417.13m-4.63m4.68bn652.00--5.46--11.23-0.0112-0.01121.012.070.34981.4533.50639,765.50-0.3445-4.21-0.411-4.7160.2270.96-0.985-15.761.61--0.1327--77.99-2.0475.59---7.30--
Qingdao NovelBeam Technology Co Ltd413.02m124.91m4.72bn797.0037.713.68--11.431.041.043.4410.630.29620.86634.68518,221.708.8114.679.3716.6363.8562.3229.7334.159.12--0.026233.55-1.3118.58-20.1921.7110.45--
Jiangsu Bioperfectus Technologies Co Ltd394.84m-170.68m4.76bn684.00--1.45--12.07-2.91-2.916.7458.000.0970.97472.52577,244.10-4.1925.41-4.7431.2665.7063.37-43.2332.864.96--0.090330.54-92.7211.81-120.45--2.43--
TINAVI Medical Technologies Co Ltd168.49m-160.48m4.99bn339.00--4.23--29.61-0.3585-0.35850.37562.620.10751.484.73475,961.90-10.24-7.86-11.04-9.0768.6673.58-95.24-50.092.21--0.1532--34.4810.63-41.42--51.87--
Zhejiang Gongdong Medical Techno Co Ltd1.10bn162.27m5.03bn1.67k30.983.02--4.581.031.036.9510.570.56846.554.33656,174.208.4016.359.7119.2632.4841.1914.7721.623.00--0.052138.99-33.6115.11-66.535.1427.71--
Beijing Chunlizhengda Mdicl Instr Co Ltd924.65m158.35m5.09bn1.23k36.882.06--5.500.40780.40782.417.290.26980.53812.15751,138.904.6212.535.4915.4371.0872.7617.1226.893.80--0.000321.630.575919.40-9.7221.33-8.60--
Assure Tech Hangzhou Co Ltd590.49m90.50m5.11bn791.0056.520.9927--8.660.7120.7124.6540.530.10111.902.85746,504.601.5531.831.7138.9736.8765.8215.3047.868.66--0.012516.05-91.8425.18-95.3533.5178.77--
Hangzhou Ags Medtech Co Ltd590.12m271.52m5.17bn592.0019.042.24--8.773.363.367.3028.530.25453.2713.92996,828.3011.71--12.26--71.52--46.01--19.56--0.003--37.09--49.87------
Xiangyu Medical Co Ltd709.56m121.39m5.30bn1.82k43.012.62--7.470.770.774.5212.660.25961.0114.80390,085.104.4411.185.6213.1266.0366.7817.1232.691.43--0.141727.3352.4615.7281.0323.11132.76--
Hangzhou Alltest Biotech Co Ltd812.78m276.54m5.45bn1.09k19.671.38--6.713.503.5010.2650.020.1982.216.97743,626.506.7423.357.2226.8353.6958.3434.0339.0710.46--0.002229.79-77.7332.59-84.7526.1972.77--
Shanghai Sanyou Medical Co Ltd434.20m37.87m5.49bn466.00154.242.87--12.630.14320.14321.717.690.19510.61915.15931,756.402.099.422.4110.8570.7287.1510.7329.783.27--0.013516.21-29.0815.67-49.918.99-15.60--
Data as of Sep 13 2024. Currency figures normalised to Zhejiang Gongdong Medical Technology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

6.19%Per cent of shares held by top holders
HolderShares% Held
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 30 Jun 20241.92m1.22%
ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Jun 20241.69m1.08%
Golden Trust Sinopac Fund Management Co., Ltd.as of 30 Jun 20241.55m0.99%
CIB Fund Management Co., Ltd.as of 30 Jun 20241.02m0.65%
Caitong Securities Asset Management Co., Ltd.as of 30 Jun 2024798.00k0.51%
GF Fund Management Co., Ltd.as of 30 Jun 2024761.52k0.48%
Shanghai Panjing Investment Management Center LPas of 13 Sep 2023735.93k0.47%
China Southern Asset Management Co., Ltd.as of 30 Jun 2024490.81k0.31%
Essence Fund Co., Ltd.as of 30 Jun 2024420.51k0.27%
The Vanguard Group, Inc.as of 02 Oct 2024337.96k0.22%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.